Metabolic adaptations of micrometastases alter EV production to generate invasive microenvironments
Authors:
- Michalis GounisMGMichalis Gounis
- America V. CamposACAmerica V. Campos
- Engy ShokryESEngy Shokry
- Louise MitchellLMLouise Mitchell
- Ruhi DeshmukhRDRuhi Deshmukh
- Emmanuel DornierEmmanuel Dornier
- Nicholas RooneyNRNicholas Rooney
- Sandeep DhayadeSDSandeep Dhayade
- Luis PardoLPLuis Pardo
- Madeleine MooreMMMadeleine Moore
- David NovoDNDavid Novo
Open Access
- 9 June 2025
- journal article
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 224 (8)
Abstract
Altered cellular metabolism has been associated with the acquisition of invasive phenotypes during metastasis. To study this, we combined a genetically engineered mouse model of mammary carcinoma with syngeneic transplantation and primary tumor resection to generate isogenic cells from primary tumors and their corresponding lung micrometastases. Metabolic analyses indicated that micrometastatic cells increase proline production at the expense of glutathione synthesis, leading to a reduction in total glutathione levels. Micrometastatic cells also have altered sphingomyelin metabolism, leading to increased intracellular levels of specific ceramides. The combination of these metabolic adaptations alters extracellular vesicle (EV) production to render the microenvironment more permissive for invasion. Indeed, micrometastatic cells shut down Rab27-dependent production of EVs and, instead, switch on neutral sphingomyelinase-2 (nSM2)-dependent EV release. EVs released in an nSM2-dependent manner from micrometastatic cells, in turn, influence the ability of fibroblasts to deposit extracellular matrix, which promotes cancer cell invasiveness. These data provide evidence that metabolic rewiring drives invasive processes in metastasis by influencing EV release.Keywords
All Related Versions
Funding Information
- Beatson Advanced Imaging Resource (SCR_023875)
- Cancer Research UK (A18277, A28291, A23982, A29799, PRCBTP-May24/100005, C596/A18076, C596/A17196, A31287)
- Breast Cancer Now (2019NovPR1268)
- Medical Research Council (MR/P01058X/1)
- Pancreatic Cancer UK Research Innovation (2021RIF_22_Voorde)
- Wellcome Trust (318046)
This publication has 65 references indexed in Scilit:
- Metastatic Behavior of Breast Cancer SubtypesJournal of Clinical Oncology, 2010
- Rab27a and Rab27b control different steps of the exosome secretion pathwayNature Cell Biology, 2009
- Microenvironmental regulation of metastasisNature Reviews Cancer, 2008
- Ceramide Triggers Budding of Exosome Vesicles into Multivesicular EndosomesScience, 2008
- Models, mechanisms and clinical evidence for cancer dormancyNature Reviews Cancer, 2007
- Syndecan-4–dependent Rac1 regulation determines directional migration in response to the extracellular matrixJournal of Cell Biology, 2007
- Genes that mediate breast cancer metastasis to lungNature, 2005
- Cell Migration Analyses Within Fibroblast-Derived 3-D Matrices2005
- Multistep Nature of Metastatic InefficiencyThe American Journal of Pathology, 1998
- Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.Molecular and Cellular Biology, 1992